Positives

• Rosmarinic acid is a polyphenol found in rosemary, lemon balm, perilla, and oregano with documented anti-inflammatory, antioxidant, and antiviral activity in laboratory and animal studies, including reductions in IL-6 and TNF-α relevant to Long COVID’s inflammatory profile PMC.
  
  
• A clinical trial of perilla extract (a high-rosmarinic-acid source) showed measurable reductions in seasonal allergic rhinitis symptoms, supporting the H1-receptor and mast-cell-stabilizing mechanism that may help MCAS-overlap Long COVID patients Healthline.
  
  
• Rosmarinic acid in vitro inhibits SARS-CoV-2 spike protein binding to ACE2 and modulates inflammatory pathways relevant to post-COVID symptoms, providing a mechanistic case alongside the broader polyphenol literature PMC.
  
  

Negatives

• Patients on lemon balm and rosemary extracts standardized to rosmarinic acid commonly describe relaxation but no measurable change in fatigue or pain, with results inconsistent across small trials.
• Potency varies widely between brands because most products only declare total extract weight, not the rosmarinic acid percentage, leaving patients uncertain whether they hit the 50-300 mg/day range used in studies.

Hurdles & Side Effects

• Lemon balm extracts standardized to 14% rosmarinic acid (Cyracos-style) typically cost $20-35/month at 300 mg/day, while pure rosmarinic acid is sold as a research-grade powder and is harder to source consistently.
• Concentration varies dramatically between supplement brands, so patients often pay premium prices for products with verified COAs because cheaper rosemary capsules may contain only trace rosmarinic acid.